The use of Aspirin for cardioprotection, headache, arthritis, musculoskeletal pain among patients show a positive possible reduction in colorectal cancers risk noticed after 6 years of continuous use of Aspirin . According to US Prevention Services Task Force, it is not a recommendation for Aspirin to be used solely for prevention of the said cancer ”but rather acknowledges an additional benefit of aspirin use among a group of individuals who are already likely to benefit from aspirin for the prevention of cardiovascular events.”Simply means if you don’t have CAD or related aspirin medical treated issues, there is no point using Aspirin for fear of having cancer .
The researchers said more study is needed in ”advancing the use of aspirin as a true cancer chemopreventive agent” which will require ”additional data from dedicated randomized clinical trials regarding the ability of aspirin to protect against cancers with the definition of an effective dose, the frequency and duration of treatment” before any conclusion and recommendations can be made. The observation of the additional benefits of Aspirin was noticed in the cohorts study which was as good as”broadly representative of the US general population in terms of prevalence of risk factors and screening rates” they said.
Their findings are consistent with earlier reported preventive effects of aspirin on gastrointestinal (GI) tract cancers in previous study with a reduced rate of 15% in GI tract cancers and a significant reduction of 19% in the risk for CRC . Also the risk of gastroesophageal cancer was reduced by 15% They also demonstrated that protection against GI tract cancers occurs at relatively low doses of 0.5 – 1.5 standard tablets per week. All these results were gotten without including lifestyle parameters. The researchers noted a decline of 3% in all cancers. ”Regular aspirin use was not associated with a reduced risk for breast, advanced prostate, or lung cancers in these analyses” says Dr.Eduardo.
Source Eduardo Vilar, MD Division of Cancer Prevention and Population Sciences, Department of Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center, Houston ,Journal JAMA Oncology published on 3rd March,2016
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Everyone wants a doctor that shows you that you are important to them and not just any other patient or number on their filing list. At Emobile, it’s not only the Consultant that shows you this. From the front desk to the nurses station up to the consultant, that’s the experience you get. This is indeed a hospital worth recommending to so many and I have.
